Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $12.75
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has earned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among […]
More Stories
Cintas Co. (NASDAQ:CTAS) Sees Significant Growth in Short Interest
Cintas Co. (NASDAQ:CTAS – Get Free Report) was the target of a significant increase in short interest in December. As...
BrightSphere Investment Group Inc. (NYSE:BSIG) Short Interest Up 6.9% in December
BrightSphere Investment Group Inc. (NYSE:BSIG – Get Free Report) was the target of a significant increase in short interest in...
Short Interest in Chipotle Mexican Grill, Inc. (NYSE:CMG) Increases By 6.2%
Chipotle Mexican Grill, Inc. (NYSE:CMG – Get Free Report) was the target of a significant growth in short interest in...
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Short Interest Update
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) saw a large increase in short interest during the month of December....
General Dynamics Co. (NYSE:GD) Sees Significant Increase in Short Interest
General Dynamics Co. (NYSE:GD – Get Free Report) was the target of a large increase in short interest in the...
Byline Bancorp, Inc. (NYSE:BY) Short Interest Update
Byline Bancorp, Inc. (NYSE:BY – Get Free Report) was the recipient of a large growth in short interest in the...